Name: Context Therapeutics Inc. (CNTX) Cash Flow Statement
Creator: FinSpry

Context Therapeutics Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scale:

Scroll to see more

Cash flow statement showing operating, investing, and financing activities for Context Therapeutics Inc. (CNTX) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Operating Activities
Net Income	-26.73	-23.96	-14.84	-10.46	6.64
Depreciation & Amortization	0.01	0.01	0.01	0.00	0.00
Stock Based Compensation	0.84	1.08	0.98	0.51	0.22
Change in Working Capital	-3.48	1.78	-0.28	-2.22	1.32
Change in Accounts Payable	-0.95	1.45	-0.79	-0.87	0.56
Change in Other Working Capital	-2.53	0.33	0.51	-1.36	0.76
Other Operating Activities	14.79	1.07	1.48	4.01	-9.22
Net Cash from Operating Activities	-14.56	-21.05	-13.55	-8.80	-1.03
Investing Activities
Capital Expenditures	-14.76	0.00	-0.04	-0.25	0.00
Acquisitions	0.00	0.00	-0.50	-0.25	0.00
Sales/Maturities of Investments	0.00	0.00	-0.50	-0.25	0.00
Other Investing Activities	-14.75	0.00	0.00	0.00	0.00
Net Cash from Investing Activities	-14.76	0.00	-0.54	-0.25	0.00
Financing Activities
Common Stock Issued	109.29	0.00	-0.10	53.41	0.00
Other Financing Activities	0.00	0.00	-0.10	0.00	0.00
Net Cash from Financing Activities	109.29	0.00	-0.10	58.39	1.15
Summary
Net Change in Cash	79.98	-21.05	-14.19	49.34	0.11
Cash at Beginning of Period	14.45	35.50	49.69	0.34	0.00
Cash at End of Period	94.43	14.45	35.50	49.69	0.00
Free Cash Flow	-29.31	-21.05	-13.59	-8.80	-1.03